- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07422415
Effects of E-Cigarette Use Among Young Egyptian Adults
February 18, 2026 updated by: Mohamed Abd Elmoniem Mohamed, Mansoura University Hospital
Respiratory, Functional, and Radiological Effects of E-Cigarette Use Among Young 1 Egyptian Adults: A Cross-Sectional Study
Electronic cigarettes (E-cigarettes) have gained significant popularity as an alternative to traditional combustible tobacco cigarette smoking.
E-cigarettes are marketed as a safer alternative to conventional smoking forms.
Many chronic smokers suppose that e-cigarettes are risk-free and can be used effectively as a smoking cessation tool.
The market size of e-cigarette is increasing because of its rising popularity among the youth even though it is not an approved Food and Drug Administration (FDA) product yet
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Most daily life activities as walking and household chores that affect quality of life are performed at a submaximal level of exertion.
E-cigarettes may affect overall physical fitness and cardiovascular health.
It is important to evaluate responses of all body systems interacting during exercise, including cardiovascular and pulmonary function, systemic circulation, peripheral circulation, blood, neuromuscular units, muscle metabolism, oxygen transport and utilization within skeletal muscles.
The knowledge gap regarding the potential negative health effects of E-cigarettes is crucial, as e-cigarettes are newly prevailing smoking tools that are gaining rising popularity among the youth.
Additionally, the false perception of the unregulated electronic cigarette smoking as a safe recreational habit may increase the prevalence among the population.
The aim of this work is to assess the clinical and functional impact of E-cigarettes garette use in young Egyptian adults, and to evaluate the role of chest CT in follow-up of identified abnormalities.
Study Type
Observational
Enrollment (Actual)
104
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Al Mansurah, Egypt, 35516
- Mohamed AbdElmoniem
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
A total of 104 participants were enrolled and allocated into two equal groups: Group I: Exclusive e-cigarette users (n = 52) and Group II: Non-smoker controls (n = 52).
Description
Inclusion Criteria:
- Age > 18 years
- E-cigarette users (≥6 months of regular use)
- No prior history of chronic pulmonary disease
Exclusion Criteria:
- Dual users (both e-cigarettes and traditional tobacco)
- History of chronic respiratory illnesses (e.g., asthma, COPD)
- immunocompromised
- Systemic chronic diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Non-smoker controls
Patients were included with Age ≥ 18 years, Non smokers
|
Spirometry was performed measure forced expiratiory volume at 1st second (FEV₁), forced vital capacity (FVC), and FEV₁/FVC ratio.
|
|
Exclusive e-cigarette users
Patients were included if Age ≥ 18 years, Exclusive e-cigarette users (Participants were considered exclusive e-cigarette users if they had used e-cigarettes regularly for ≥ 6 months).
|
Spirometry was performed measure forced expiratiory volume at 1st second (FEV₁), forced vital capacity (FVC), and FEV₁/FVC ratio.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spirometer parameters assessment
Time Frame: 3 months
|
Spirometry was performed to measure forced expiratory volume at 1st second (FEV₁)
|
3 months
|
|
Spirometer assessment
Time Frame: 3 months
|
Spirometry was performed to measure FEV₁/FVC ratio
|
3 months
|
|
Spirometer
Time Frame: 3 months
|
Spirometry was performed to measure forced vital capacity (FVC)
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mohamed AbdElmoniem, Lecturer of chest medicine faculty of medicine Mansoura university
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2025
Primary Completion (Actual)
December 31, 2025
Study Completion (Actual)
February 1, 2026
Study Registration Dates
First Submitted
February 12, 2026
First Submitted That Met QC Criteria
February 18, 2026
First Posted (Actual)
February 20, 2026
Study Record Updates
Last Update Posted (Actual)
February 20, 2026
Last Update Submitted That Met QC Criteria
February 18, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R.25.09.3347
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on E Cigarette Use
-
University of VermontNational Institute on Drug Abuse (NIDA)Completed
-
University of Southern CaliforniaCompletedElectronic Cigarette Use | Cigarette Smoking | Cigarette Use, Electronic | E-Cig UseUnited States
-
BIDI VaporCompletedCigarette Smoking | E-cigarette UsePoland
-
Jovan Gwon, PhD, RN, FIAANRecruiting
-
Duke UniversityGeorgetown University; University of MichiganWithdrawnSmoking | Cigarette Smoking | E-cigarette Use
-
University of California, San DiegoNot yet recruitingE Cigarette Use
-
Western University, CanadaLondon Health Sciences CentreRecruitingE Cigarette UseCanada
-
Ohio State University Comprehensive Cancer CenterCompletedE-cigarette UseUnited States
-
University of CincinnatiActive, not recruitingE-cigarette UseUnited States
-
Yale UniversityNational Cancer Institute (NCI)RecruitingSmoking Cessation | Cigarette Smoking | E-Cigarette UseUnited States
Clinical Trials on Pulmonary Function test
-
Ankara City Hospital BilkentCompletedAnesthesia | Adolescent Idiopathic Scoliosis | Pulmonary Function Test, PreoperativeTurkey
-
Poitiers University HospitalCompletedRespiratory Insufficiency | Systemic Sclerosis | Pulmonary Function Test | Diaphragm Defect | Muscular Weakness | Diaphragmatic ElectromyographyFrance
-
Assiut UniversityUnknown
-
University Hospital, MontpellierUnknownFood Allergy Suspected | Food Allergy ProvedFrance
-
State University of New York - Upstate Medical...Mitsubishi Tanabe Pharma America Inc.Enrolling by invitation
-
AstraZenecaNot yet recruiting
-
Centre Hospitalier Universitaire Saint PierreRecruiting
-
Assiut UniversityCompletedPulmonary Hypertension | Interstitial Lung DiseaseEgypt
-
Hopital FochCompleted
-
Medical University InnsbruckBoehringer IngelheimRecruitingConnective Tissue Diseases | Systemic Sclerosis | Interstitial Lung DiseaseAustria